.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
The Odisha government recently took decisive action regarding Odisha health scheme violations. Health Minister Mukesh Mahaling announced the de-rostering of 10 private hospitals from the Ayushman Bharat-Gopabandhu Jana Arogya Yojana (AB-GJAY). Furthermore, authorities penalised another facility in Ganjam for submitting duplicate claims. This move highlights the state's commitment to maintaining strict oversight of healthcare providers. Consequently, these measures aim to protect the integrity of cashless healthcare benefits for eligible citizens.
Government officials examined 56 specific complaints concerning irregularities by empanelled hospitals. Following a formal review, they issued show-cause notices to several facilities. Consequently, ten hospitals faced suspension while one hospital received a financial penalty. These facilities operate in multiple districts, including Cuttack, Ganjam, and Khurda. Specifically, the government acted against violations such as negligence, lack of proper clinical registration, and scheme guideline breaches. One case even involved the tragic death of a woman, prompting immediate administrative intervention.
Minister Mahaling emphasised that the government is closely monitoring all healthcare providers under the scheme. This oversight ensures that beneficiaries receive high-quality, cashless treatment as promised. Additionally, the government recovered a penalty of Rs 58,500 from a hospital in Ganjam for duplicate claim submissions. The health department continues to initiate proceedings whenever it receives valid complaints. Therefore, hospitals must adhere strictly to established norms to avoid show-cause proceedings. These efforts strengthen the Ayushman Bharat-Gopabandhu Jana Arogya Yojana's ability to serve the public effectively across Odisha.
Q1: Why were the ten private hospitals suspended in Odisha?
The hospitals faced suspension due to irregularities, violation of scheme norms, lack of valid clinical establishment registrations, and negligence in patient care.
Q2: What is the primary goal of the Ayushman Bharat-Gopabandhu Jana Arogya Yojana?
The scheme provides cashless healthcare benefits to eligible beneficiaries throughout Odisha, ensuring access to high-quality medical treatment without financial burden.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
The Odisha government has de-rostered 10 private hospitals and penalised another for violating Ayushman Bharat-Gopabandhu Jana Arogya Yojana guidelines....
5 months ago
A New York City initiative successfully distributed over 48,000 COVID-19 oral antiviral prescriptions through rapid home delivery in 2022. With 92% delivered within 24 hours, the program safeguarded vulnerable and elderly populations, establishing an equitable framework for emergency drug distribution.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today
